Product Information

SYMBRAVO 20-10 MG TABLET is a brand product labeled by Axsome Therapeutics, Inc., priced at $122.6975 per EA under NDC 81968002009. Its NADAC has been published 44 times since Oct 22, 2025.

FDA first approved this application on Jan 30, 2025.

SYMBRAVO 20-10 MG TABLET

meloxicam, rizatriptan
$122.6975per EA

Strength

20; 10 mg/1; mg/1

NDC

81968002009

Classification

Brand

Dosage Form

TABLET

Route

ORAL

Effective Date

8/19/2026

Approval Type

New Drug (NDA)

FDA Application

NDA215431

FDA Approved

1/30/2025

On Market Since

5/19/2025

Pharmacological Classes

Anti-Inflammatory Agents
Non-Steroidal
Cyclooxygenase Inhibitors
Nonsteroidal Anti-inflammatory Drug
Serotonin 1b Receptor Agonists
Serotonin 1d Receptor Agonists
Serotonin-1b and Serotonin-1d Receptor Agonist

Price Statistics

The NADAC for SYMBRAVO 20-10 MG TABLET has been published 44 times since Oct 22, 2025, and over the history we have for it it has held within roughly two percent of its current level. The table below summarizes its recorded NADAC range and movement.

Current price$122.6975 per EA
All-time high$122.8814 (Dec 10, 2025)
All-time low$122.6661 (Jul 22, 2026)
52-week high$122.8814
52-week low$122.6661
Median price$122.6959
Average price$122.7248
Largest weekly change-0.2% (Dec 17, 2025)
Weeks tracked44
Tracking sinceOct 22, 2025

Price History

1W

+0.0%

1M

+0.0%

3M

+0.0%

6M

-0.1%

1Y

N/A

3Y

N/A

5Y

N/A

All

+0.0%

Generic Alternatives

No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the meloxicam, rizatriptan market page.

Lowest-Cost Alternatives

No alternatives available

No alternatives found with the same active ingredient and strength in a comparable dosage form.

Frequently asked questions

What is the NADAC price of SYMBRAVO 20-10 MG TABLET?

The current National Average Drug Acquisition Cost (NADAC) for SYMBRAVO 20-10 MG TABLET, manufactured by Axsome Therapeutics, Inc., is $122.6975 per EA (NDC 81968002009), effective Aug 19, 2026.

How has the price of SYMBRAVO 20-10 MG TABLET changed over time?

Over the history we have for it, the NADAC for SYMBRAVO 20-10 MG TABLET has held within roughly two percent of its current level. It has been tracked across 44 weekly CMS publications since Oct 22, 2025.

What are the highest and lowest recorded NADAC prices for SYMBRAVO 20-10 MG TABLET?

Since Oct 22, 2025, the NADAC for SYMBRAVO 20-10 MG TABLET has ranged from a low of $122.6661 (Jul 22, 2026) to a high of $122.8814 (Dec 10, 2025), with a median of $122.6959 per EA.

Are there cheaper alternatives to SYMBRAVO 20-10 MG TABLET?

No other NADAC-published product currently shares the active ingredient and strength of SYMBRAVO 20-10 MG TABLET in a comparable dosage form, so no direct lower-cost alternative is listed.

Who manufactures SYMBRAVO 20-10 MG TABLET?

SYMBRAVO 20-10 MG TABLET (NDC 81968002009) is labeled by Axsome Therapeutics, Inc., and CMS classifies it as a brand product.